(Q48271162)

10 February 2018

title

Phosphoinositide hydrolysis in vivo with group I metabotropic glutamate receptor agonists. (English)

1 reference

10 February 2018

author name string

M P Johnson

series ordinal

1

1 reference

10 February 2018

M Chamberlain

series ordinal

2

1 reference

10 February 2018

G M Kelly

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

821

1 reference

10 February 2018

page(s)

539-545

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

Increased brain myo-inositol 1-phosphate in lithium-treated rats.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Reduced Brain Inositol in Lithium-treated Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Activation of phospholipases C and D by the novel metabotropic glutamate receptor agonist tADA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Excitatory amino acid neurotoxicity and neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Glutamate receptors in the mammalian central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

The muscarinic receptor agonist L-658,903 modulates the in vivo accumulation of inositol monophosphates in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Manganese stimulates the incorporation of [3H]inositol into a pool of phosphatidylinositol in brain that is not coupled to agonist-induced hydrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Novel functions for subtypes of metabotropic glutamate receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

3,5-dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Metabotropic glutamate receptors and neuronal degenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

Induction or protection of limbic seizures in mice by mGluR subtype selective agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901065-3

10.1016/S0006-8993(99)01065-3

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

10064844

1 reference

10 February 2018